human
bocaviru
common
caus
respiratori
tract
infect
rti
young
children
caus
seriou
lower
rti
children
younger
six
year
age
diagnosi
infect
tradit
base
qualit
pcr
detect
viral
dna
recent
studi
howev
shown
clinic
valu
approach
low
due
persist
dna
airway
lead
frequent
detect
low
concentr
healthi
children
clinic
specif
mrna
detect
shown
superior
dna
detect
detect
antigen
anoth
diagnost
approach
autom
antigen
test
base
immunometr
detect
recent
develop
shown
promis
preliminari
studi
antigen
detect
well
suit
autom
pointofcar
diagnost
may
benefici
make
diagnosi
provid
rapid
specif
result
aim
studi
compar
antigen
detect
mrna
rtpcr
quantit
dna
detect
qpcr
nasopharyng
swab
np
children
rti
antigen
test
part
complet
autom
system
multianalyt
identif
respiratori
virus
bacteria
influenzaviru
influenzaviru
b
respiratori
syncyti
viru
human
coronaviru
human
metapneumoviru
human
bocaviru
parainfluenzaviru
type
parainfluenzaviru
type
parainfluenzaviru
type
adenoviru
streptococcu
pneumonia
ivdc
approv
diagnost
test
respi
test
arcdia
intern
ltd
turku
finland
immunoassay
base
separationfre
twophoton
excit
fluorometri
target
capsid
protein
maripoc
test
report
strong
posit
sampl
min
lowposit
neg
result
confirm
h
maripoc
npss
dilut
ml
maripoc
rti
sampl
buffer
rapid
prospect
onsit
test
randomaccess
immunoassay
analyz
test
routin
use
pediatr
emerg
depart
turku
univers
hospit
rapid
pointofcar
diagnost
rti
throughout
studi
period
accord
local
guidelin
maripoc
antigen
test
use
children
hospit
acut
rti
pediatr
emerg
depart
serv
popul
children
adolesc
year
age
receiv
patient
mostli
referr
primari
care
clinic
major
children
hospit
rti
younger
year
age
lower
rti
turku
univers
hospit
approv
studi
waiver
inform
consent
ethic
committe
studi
involv
reanalysi
deidentifi
sampl
collect
part
routin
care
sampl
analyz
duplic
dna
qpcr
mrna
reversetranscript
rt
pcr
describ
previous
cutoff
high
viral
load
dna
qpcr
copiesml
correl
mrna
high
dna
load
antigen
measur
phi
coeffici
correl
sensit
specif
posit
predict
valu
ppv
antigen
test
calcul
use
mrna
rtpcr
dna
qpcr
refer
dna
high
dna
load
mrna
antigen
detect
npa
sampl
respect
tabl
sampl
posit
dna
high
dna
load
posit
mrna
antigen
sampl
high
dna
load
posit
mrna
antigen
wherea
none
low
dnaload
sampl
harbor
mrna
antigen
posit
antigen
test
result
avail
min
nine
sampl
four
remain
result
avail
two
hour
presenc
antigen
correl
well
mrna
high
dna
load
phi
coeffici
correl
mrna
antigen
wherea
mrna
high
dna
load
specif
ppv
antigen
test
excel
sensit
lower
mrna
rtpcr
refer
specif
sensit
ppv
respect
high
dna
load
qpcr
refer
figur
tabl
wide
use
qualit
dna
pcr
yield
result
low
clinic
specif
low
ppv
confirm
mrna
rtpcr
refer
qualit
dna
pcr
specif
ppv
respect
tabl
serolog
test
base
detect
igm
increas
igg
pair
serum
sampl
wellestablish
refer
method
clinic
studi
howev
sera
obtain
children
includ
studi
instead
use
mrna
detect
high
dna
load
basi
calcul
specif
sensit
ppv
mrna
marker
activ
transcrib
viru
ongo
infect
rapidli
declin
dna
load
normal
outcom
acut
infect
mrna
test
perform
well
studi
provid
support
use
refer
furthermor
high
dna
load
copiesml
nasopharyng
secret
shown
better
diagnost
criterion
mere
dna
detect
endpoint
pcr
two
test
togeth
therefor
form
good
basi
evalu
antigen
test
detect
rate
dna
mrna
high
dna
load
copiesml
children
rti
agreement
previou
report
literatur
taken
togeth
result
suggest
fifth
children
dna
nasopharynx
acut
infect
studi
sampl
store
two
year
therefor
degrad
rna
exclud
storag
temperatur
recommend
rna
usual
sensit
antigen
test
could
overestim
rna
degrad
occur
howev
mrna
posit
rate
reflect
high
dna
load
indic
effect
small
furthermor
amplicon
bp
probabl
degrad
within
target
sequenc
low
explain
limit
effect
rna
degrad
result
among
adult
rti
dna
rare
detect
sampl
size
studi
adult
small
conclud
clinic
signific
posit
conclud
antigen
detect
excel
diagnos
acut
infect
children
compar
two
independ
refer
assay
antigen
test
show
substanti
higher
clinic
specif
ppv
commonli
use
qualit
dna
pcr
sensit
antigen
test
lower
pcr
advantag
rapid
test
avail
pointofcar
use
posit
result
usual
avail
min
result
faster
diagnosi
tradit
method
make
test
attract
emerg
room
outpati
use
supplementari
test
measur
dna
load
mrna
specif
antibodi
valu
higher
sensit
inpati
set
requir
